Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis
作者： Lucilla Parnetti , Elena Chipi , Nicola Salvadori , Katia D’Andrea , Paolo Eusebi
DOI: 10.1186/S13195-018-0459-7
关键词:
摘要: … preclinical AD stages, where Stage 3 shows a risk of progression comparable to MCI due to AD. … yet fulfilling MCI criteria. The possibility to define, in the clinical routine, a patient as “pre-…
biomedcentral.com
springer.com
figshare.com
paperity.org参考文章(100)
F. L. Besson, R. La Joie, L. Doeuvre, M. Gaubert, F. Mezenge, S. Egret, B. Landeau, L. Barre, A. Abbas, M. Ibazizene, V. de La Sayette, B. Desgranges, F. Eustache, G. Chetelat, Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease The Journal of Neuroscience. ,vol. 35, pp. 10402- 10411 ,(2015) , 10.1523/JNEUROSCI.0150-15.2015
Simone Hollands, Yen Ying Lim, Rachel Buckley, Robert H. Pietrzak, Peter J. Snyder, David Ames, Kathryn A. Ellis, Karra Harrington, Nicola Lautenschlager, Ralph N. Martins, Colin L. Masters, Victor L. Villemagne, Christopher C. Rowe, Paul Maruff, , Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults. Journal of Alzheimer's Disease. ,vol. 43, pp. 677- 686 ,(2014) , 10.3233/JAD-140678
Shizuo Hatashita, Hidetomo Yamasaki, Clinically Different Stages of Alzheimer's Disease Associated by Amyloid Deposition with [11C]-PIB PET Imaging Journal of Alzheimer's Disease. ,vol. 21, pp. 995- 1003 ,(2010) , 10.3233/JAD-2010-100222
Matthew R. Brier, John E. McCarthy, Tammie L.S. Benzinger, Ari Stern, Yi Su, Karl A. Friedrichsen, John C. Morris, Beau M. Ances, Andrei G. Vlassenko, Local and distributed PiB accumulation associated with development of preclinical Alzheimer's disease. Neurobiology of Aging. ,vol. 38, pp. 104- 111 ,(2016) , 10.1016/J.NEUROBIOLAGING.2015.10.025
Shannon L. Risacher, Sungeun Kim, Kwangsik Nho, Tatiana Foroud, Li Shen, Ronald C. Petersen, Clifford R. Jack, Laurel A. Beckett, Paul S. Aisen, Robert A. Koeppe, William J. Jagust, Leslie M. Shaw, John Q. Trojanowski, Michael W. Weiner, Andrew J. Saykin, , APOE
effect on Alzheimer's disease biomarkers in older adults with significant memory concern Alzheimer's & Dementia. ,vol. 11, pp. 1417- 1429 ,(2015) , 10.1016/J.JALZ.2015.03.003
Ronald C. Petersen, John C. Morris, Mild Cognitive Impairment as a Clinical Entity and Treatment Target JAMA Neurology. ,vol. 62, pp. 1160- 1163 ,(2005) , 10.1001/ARCHNEUR.62.7.1160
Barry Reisberg, Leslie Prichep, Lisa Mosconi, E. Roy John, Lidia Glodzik-Sobanska, Istvan Boksay, Isabel Monteiro, Carol Torossian, Alok Vedvyas, Nauman Ashraf, Imran A. Jamil, Mony J. de Leon, The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease Alzheimer's & Dementia. ,vol. 4, pp. S98- S108 ,(2008) , 10.1016/J.JALZ.2007.11.017
David S. Knopman, Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, Prashanthi Vemuri, Val J. Lowe, Kejal Kantarci, Jeffrey L. Gunter, Matthew L. Senjem, Michelle M. Mielke, Rosebud O. Roberts, Bradley F. Boeve, Ronald C. Petersen, Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis. JAMA Neurology. ,vol. 70, pp. 1030- 1038 ,(2013) , 10.1001/JAMANEUROL.2013.182
Jessica B. Langbaum, Suzanne B. Hendrix, Napatkamon Ayutyanont, Kewei Chen, Adam S. Fleisher, Raj C. Shah, Lisa L. Barnes, David A. Bennett, Pierre N. Tariot, Eric M. Reiman, An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease Alzheimers & Dementia. ,vol. 10, pp. 666- 674 ,(2014) , 10.1016/J.JALZ.2014.02.002
Clifford R Jack, David S Knopman, William J Jagust, Ronald C Petersen, Michael W Weiner, Paul S Aisen, Leslie M Shaw, Prashanthi Vemuri, Heather J Wiste, Stephen D Weigand, Timothy G Lesnick, Vernon S Pankratz, Michael C Donohue, John Q Trojanowski, Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurology. ,vol. 12, pp. 207- 216 ,(2013) , 10.1016/S1474-4422(12)70291-0